Clinical Trial Update: Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy results for Mix Vaccine in patients with lung cancer from a Phase 1/2 study that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Mix Vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Lung Neoplasms | Phase 1, Phase 2 | Status: COMPLETED